Login / Signup

Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust.

Valeria CasilloStefania CerriAndrea CiervoMariarita StendardoLamberto ManzoliMaria Elena FlaccoMaurizio MannoMarialuisa BocchinoFabrizio LuppiPiera Boschetto
Published in: BMC pulmonary medicine (2019)
Occupational dust exposure lasting 10 years or more does not seem to influence the therapeutic effects of antifibrotics and the prognostic predictors in patients with IPF.
Keyphrases
  • idiopathic pulmonary fibrosis
  • interstitial lung disease
  • health risk
  • health risk assessment
  • human health
  • polycyclic aromatic hydrocarbons
  • rheumatoid arthritis
  • climate change